Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.
As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.
April 26, 2022Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing improved outcomes for pancreatic cancer patients through the use… Read More
Tags: Cancer, Life Insurance, Pancreatic cancer, Study
April 7, 2022Consulting medical director Michael Fulks, MD, comments on recent changes to the leading causes of death because of COVID-19, drugs,… Read More
Tags: Cancer, Covid 19, Drug overdose, Life Insurance, Mortality
February 15, 2022The conclusions of the Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference were recently published.1 This expert panel started with… Read More
Tags: eGFR, Kidney, Life Insurance, Mortality, Risk
August 5, 2021CRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic patients…. Read More
Tags: Covid 19, Covid 19 Crisis, Laboratory, Life Insurance, Mortality
July 14, 2021By 2018, over 42% of US adults were obese (BMI 30+) with little variation by age and sex, and almost… Read More
Tags: Bmi, Insurance, Life Insurance, Obesity, Type 2 Diabetes
June 28, 2021Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More
Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement
June 17, 2021Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More
Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality
March 31, 2021Urine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently… Read More
Tags: Healthcare, Kidney, Life Insurance, Medical Research, Mortality
January 7, 2021Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More
Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management
December 14, 2020See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More
Tags: Acquisition, Business, Laboratory, Life Insurance, Mortality